I’ve returned to Seeking Alpha effective in February of this year endorsing four stocks – Synergy (SGYP); Seattle Genetics (SGEN); Celldex (CLDX) and Amarin (AMRN), all four of which have appreciated since publication.
In the near future, I plan on publishing a video with a risk/reward assessment tool to help you and I make better biotech investment decisions. This sector, as I’ve repeatedly said, is more gambling than investment and any process that can aid us in our decision making is worthy of exploration. Therefore, the Scrying Biotech Reward Matrix, pictured above, is coming soon. Look for it!
And always be well….